HEADER STRUCTURAL PROTEIN 09-NOV-21 7Q6S TITLE KEAP1 COMPOUND COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: KELCH-LIKE ECH-ASSOCIATED PROTEIN 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: CYTOSOLIC INHIBITOR OF NRF2,INRF2,KELCH-LIKE PROTEIN 19; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: KEAP1, INRF2, KIAA0132, KLHL19; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS MACROCYCLE COMPLEX, STRUCTURAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR P.JOHANSSON REVDAT 2 31-JAN-24 7Q6S 1 REMARK REVDAT 1 16-MAR-22 7Q6S 0 JRNL AUTH F.BEGNINI,S.GESCHWINDNER,P.JOHANSSON,L.WISSLER,R.J.LEWIS, JRNL AUTH 2 E.DANELIUS,A.LUTTENS,P.MATRICON,J.CARLSSON,S.LENDERS, JRNL AUTH 3 B.KONIG,A.FRIEDEL,P.SJO,S.SCHIESSER,J.KIHLBERG JRNL TITL IMPORTANCE OF BINDING SITE HYDRATION AND FLEXIBILITY JRNL TITL 2 REVEALED WHEN OPTIMIZING A MACROCYCLIC INHIBITOR OF THE JRNL TITL 3 KEAP1-NRF2 PROTEIN-PROTEIN INTERACTION. JRNL REF J.MED.CHEM. V. 65 3473 2022 JRNL REFN ISSN 0022-2623 JRNL PMID 35108001 JRNL DOI 10.1021/ACS.JMEDCHEM.1C01975 REMARK 2 REMARK 2 RESOLUTION. 2.14 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.8 (24-FEB-2021) REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.14 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 101.06 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 66.0 REMARK 3 NUMBER OF REFLECTIONS : 42464 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.212 REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.232 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2122 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.14 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.31 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 6.71 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 801 REMARK 3 BIN R VALUE (WORKING SET) : 0.3006 REMARK 3 BIN FREE R VALUE : 0.3352 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.76 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 49 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4372 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 44 REMARK 3 SOLVENT ATOMS : 186 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 66.29 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.76910 REMARK 3 B22 (A**2) : 0.37210 REMARK 3 B33 (A**2) : 2.39700 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.320 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.229 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.187 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.226 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.187 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.944 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.930 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4526 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6169 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1485 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 796 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4526 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 561 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3571 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.00 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 4.06 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.76 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -29.1394 22.4362 -11.8571 REMARK 3 T TENSOR REMARK 3 T11: -0.3177 T22: -0.1886 REMARK 3 T33: -0.2899 T12: -0.0262 REMARK 3 T13: 0.0208 T23: -0.0720 REMARK 3 L TENSOR REMARK 3 L11: 4.1514 L22: 2.0017 REMARK 3 L33: 1.2078 L12: 0.7661 REMARK 3 L13: 0.0016 L23: 0.1078 REMARK 3 S TENSOR REMARK 3 S11: -0.1181 S12: 0.4569 S13: 0.2142 REMARK 3 S21: -0.1993 S22: 0.1259 S23: 0.0488 REMARK 3 S31: -0.1888 S32: -0.0765 S33: -0.0078 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): -3.1510 9.2730 -38.5737 REMARK 3 T TENSOR REMARK 3 T11: -0.3133 T22: -0.3995 REMARK 3 T33: -0.3062 T12: -0.0441 REMARK 3 T13: 0.1176 T23: -0.0451 REMARK 3 L TENSOR REMARK 3 L11: 2.4002 L22: 2.9375 REMARK 3 L33: 2.1518 L12: 1.2962 REMARK 3 L13: 0.4880 L23: 0.4632 REMARK 3 S TENSOR REMARK 3 S11: 0.1976 S12: -0.2713 S13: 0.0056 REMARK 3 S21: 0.0829 S22: -0.2976 S23: -0.0566 REMARK 3 S31: 0.1274 S32: -0.0777 S33: 0.1000 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7Q6S COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-NOV-21. REMARK 100 THE DEPOSITION ID IS D_1292119134. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-MAY-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : MAX IV REMARK 200 BEAMLINE : BIOMAX REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97625 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : STARANISO REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 42464 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.130 REMARK 200 RESOLUTION RANGE LOW (A) : 101.100 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 65.8 REMARK 200 DATA REDUNDANCY : 6.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.13 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.37 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1ZGK REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): NULL REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.49 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CRYSTALS WERE GROWN AT 20 C IN SITTING REMARK 280 DROPS USING 200 NL OF PROTEIN (11-13 MG/ML) AND 200 NL OF WELL REMARK 280 SOLUTION (3.7-4.1 M AMMONIUM ACETATE, 0.09 M SODIUM ACETATE PH REMARK 280 4.6 AND 10 MM CADMIUM CHLORIDE)., VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 37.70000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 101.06300 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.78350 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 101.06300 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 37.70000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.78350 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 315 REMARK 465 ARG A 316 REMARK 465 GLY A 317 REMARK 465 SER A 318 REMARK 465 ALA A 319 REMARK 465 GLY A 320 REMARK 465 ALA A 321 REMARK 465 PRO A 322 REMARK 465 LYS A 323 REMARK 465 VAL A 324 REMARK 465 PRO B 315 REMARK 465 ARG B 316 REMARK 465 GLY B 317 REMARK 465 SER B 318 REMARK 465 ALA B 319 REMARK 465 GLY B 320 REMARK 465 ALA B 321 REMARK 465 PRO B 322 REMARK 465 LYS B 323 REMARK 465 VAL B 324 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 336 -29.39 71.71 REMARK 500 GLN A 528 -45.64 -134.32 REMARK 500 HIS A 575 -39.21 -154.38 REMARK 500 ARG B 336 -29.31 71.24 REMARK 500 GLN B 528 -43.59 -143.74 REMARK 500 REMARK 500 REMARK: NULL DBREF 7Q6S A 321 609 UNP Q14145 KEAP1_HUMAN 321 609 DBREF 7Q6S B 321 609 UNP Q14145 KEAP1_HUMAN 321 609 SEQADV 7Q6S PRO A 315 UNP Q14145 EXPRESSION TAG SEQADV 7Q6S ARG A 316 UNP Q14145 EXPRESSION TAG SEQADV 7Q6S GLY A 317 UNP Q14145 EXPRESSION TAG SEQADV 7Q6S SER A 318 UNP Q14145 EXPRESSION TAG SEQADV 7Q6S ALA A 319 UNP Q14145 EXPRESSION TAG SEQADV 7Q6S GLY A 320 UNP Q14145 EXPRESSION TAG SEQADV 7Q6S ALA A 540 UNP Q14145 GLU 540 CONFLICT SEQADV 7Q6S ALA A 542 UNP Q14145 GLU 542 CONFLICT SEQADV 7Q6S PRO B 315 UNP Q14145 EXPRESSION TAG SEQADV 7Q6S ARG B 316 UNP Q14145 EXPRESSION TAG SEQADV 7Q6S GLY B 317 UNP Q14145 EXPRESSION TAG SEQADV 7Q6S SER B 318 UNP Q14145 EXPRESSION TAG SEQADV 7Q6S ALA B 319 UNP Q14145 EXPRESSION TAG SEQADV 7Q6S GLY B 320 UNP Q14145 EXPRESSION TAG SEQADV 7Q6S ALA B 540 UNP Q14145 GLU 540 CONFLICT SEQADV 7Q6S ALA B 542 UNP Q14145 GLU 542 CONFLICT SEQRES 1 A 295 PRO ARG GLY SER ALA GLY ALA PRO LYS VAL GLY ARG LEU SEQRES 2 A 295 ILE TYR THR ALA GLY GLY TYR PHE ARG GLN SER LEU SER SEQRES 3 A 295 TYR LEU GLU ALA TYR ASN PRO SER ASP GLY THR TRP LEU SEQRES 4 A 295 ARG LEU ALA ASP LEU GLN VAL PRO ARG SER GLY LEU ALA SEQRES 5 A 295 GLY CYS VAL VAL GLY GLY LEU LEU TYR ALA VAL GLY GLY SEQRES 6 A 295 ARG ASN ASN SER PRO ASP GLY ASN THR ASP SER SER ALA SEQRES 7 A 295 LEU ASP CYS TYR ASN PRO MET THR ASN GLN TRP SER PRO SEQRES 8 A 295 CYS ALA PRO MET SER VAL PRO ARG ASN ARG ILE GLY VAL SEQRES 9 A 295 GLY VAL ILE ASP GLY HIS ILE TYR ALA VAL GLY GLY SER SEQRES 10 A 295 HIS GLY CYS ILE HIS HIS ASN SER VAL GLU ARG TYR GLU SEQRES 11 A 295 PRO GLU ARG ASP GLU TRP HIS LEU VAL ALA PRO MET LEU SEQRES 12 A 295 THR ARG ARG ILE GLY VAL GLY VAL ALA VAL LEU ASN ARG SEQRES 13 A 295 LEU LEU TYR ALA VAL GLY GLY PHE ASP GLY THR ASN ARG SEQRES 14 A 295 LEU ASN SER ALA GLU CYS TYR TYR PRO GLU ARG ASN GLU SEQRES 15 A 295 TRP ARG MET ILE THR ALA MET ASN THR ILE ARG SER GLY SEQRES 16 A 295 ALA GLY VAL CYS VAL LEU HIS ASN CYS ILE TYR ALA ALA SEQRES 17 A 295 GLY GLY TYR ASP GLY GLN ASP GLN LEU ASN SER VAL GLU SEQRES 18 A 295 ARG TYR ASP VAL ALA THR ALA THR TRP THR PHE VAL ALA SEQRES 19 A 295 PRO MET LYS HIS ARG ARG SER ALA LEU GLY ILE THR VAL SEQRES 20 A 295 HIS GLN GLY ARG ILE TYR VAL LEU GLY GLY TYR ASP GLY SEQRES 21 A 295 HIS THR PHE LEU ASP SER VAL GLU CYS TYR ASP PRO ASP SEQRES 22 A 295 THR ASP THR TRP SER GLU VAL THR ARG MET THR SER GLY SEQRES 23 A 295 ARG SER GLY VAL GLY VAL ALA VAL THR SEQRES 1 B 295 PRO ARG GLY SER ALA GLY ALA PRO LYS VAL GLY ARG LEU SEQRES 2 B 295 ILE TYR THR ALA GLY GLY TYR PHE ARG GLN SER LEU SER SEQRES 3 B 295 TYR LEU GLU ALA TYR ASN PRO SER ASP GLY THR TRP LEU SEQRES 4 B 295 ARG LEU ALA ASP LEU GLN VAL PRO ARG SER GLY LEU ALA SEQRES 5 B 295 GLY CYS VAL VAL GLY GLY LEU LEU TYR ALA VAL GLY GLY SEQRES 6 B 295 ARG ASN ASN SER PRO ASP GLY ASN THR ASP SER SER ALA SEQRES 7 B 295 LEU ASP CYS TYR ASN PRO MET THR ASN GLN TRP SER PRO SEQRES 8 B 295 CYS ALA PRO MET SER VAL PRO ARG ASN ARG ILE GLY VAL SEQRES 9 B 295 GLY VAL ILE ASP GLY HIS ILE TYR ALA VAL GLY GLY SER SEQRES 10 B 295 HIS GLY CYS ILE HIS HIS ASN SER VAL GLU ARG TYR GLU SEQRES 11 B 295 PRO GLU ARG ASP GLU TRP HIS LEU VAL ALA PRO MET LEU SEQRES 12 B 295 THR ARG ARG ILE GLY VAL GLY VAL ALA VAL LEU ASN ARG SEQRES 13 B 295 LEU LEU TYR ALA VAL GLY GLY PHE ASP GLY THR ASN ARG SEQRES 14 B 295 LEU ASN SER ALA GLU CYS TYR TYR PRO GLU ARG ASN GLU SEQRES 15 B 295 TRP ARG MET ILE THR ALA MET ASN THR ILE ARG SER GLY SEQRES 16 B 295 ALA GLY VAL CYS VAL LEU HIS ASN CYS ILE TYR ALA ALA SEQRES 17 B 295 GLY GLY TYR ASP GLY GLN ASP GLN LEU ASN SER VAL GLU SEQRES 18 B 295 ARG TYR ASP VAL ALA THR ALA THR TRP THR PHE VAL ALA SEQRES 19 B 295 PRO MET LYS HIS ARG ARG SER ALA LEU GLY ILE THR VAL SEQRES 20 B 295 HIS GLN GLY ARG ILE TYR VAL LEU GLY GLY TYR ASP GLY SEQRES 21 B 295 HIS THR PHE LEU ASP SER VAL GLU CYS TYR ASP PRO ASP SEQRES 22 B 295 THR ASP THR TRP SER GLU VAL THR ARG MET THR SER GLY SEQRES 23 B 295 ARG SER GLY VAL GLY VAL ALA VAL THR HET 91M A 701 43 HET CL A 702 1 HETNAM 91M (5S,8R)-16-(2,1,3-BENZOXADIAZOL-4-YL)-8-[[(2S)-1- HETNAM 2 91M ETHANOYLPYRROLIDIN-2-YL]CARBONYLAMINO]-N,N-DIMETHYL-7, HETNAM 3 91M 11-BIS(OXIDANYLIDENE)-10-OXA-3-THIA-6- HETNAM 4 91M AZABICYCLO[10.4.0]HEXADECA-1(16),12,14-TRIENE-5- HETNAM 5 91M CARBOXAMIDE HETNAM CL CHLORIDE ION FORMUL 3 91M C29 H32 N6 O7 S FORMUL 4 CL CL 1- FORMUL 5 HOH *186(H2 O) SHEET 1 AA1 4 TRP A 352 LEU A 355 0 SHEET 2 AA1 4 LEU A 342 TYR A 345 -1 N ALA A 344 O LEU A 353 SHEET 3 AA1 4 LEU A 327 ALA A 331 -1 N ILE A 328 O TYR A 345 SHEET 4 AA1 4 GLY A 605 THR A 609 -1 O ALA A 607 N TYR A 329 SHEET 1 AA2 4 ALA A 366 VAL A 370 0 SHEET 2 AA2 4 LEU A 373 VAL A 377 -1 O TYR A 375 N CYS A 368 SHEET 3 AA2 4 LEU A 393 ASN A 397 -1 O TYR A 396 N LEU A 374 SHEET 4 AA2 4 GLN A 402 PRO A 405 -1 O SER A 404 N CYS A 395 SHEET 1 AA3 2 ARG A 380 SER A 383 0 SHEET 2 AA3 2 GLY A 386 ASP A 389 -1 O THR A 388 N ASN A 381 SHEET 1 AA4 4 GLY A 417 ILE A 421 0 SHEET 2 AA4 4 HIS A 424 VAL A 428 -1 O TYR A 426 N GLY A 419 SHEET 3 AA4 4 VAL A 440 TYR A 443 -1 O GLU A 441 N ALA A 427 SHEET 4 AA4 4 TRP A 450 LEU A 452 -1 O HIS A 451 N ARG A 442 SHEET 1 AA5 2 SER A 431 HIS A 432 0 SHEET 2 AA5 2 ILE A 435 HIS A 436 -1 O ILE A 435 N HIS A 432 SHEET 1 AA6 4 GLY A 464 LEU A 468 0 SHEET 2 AA6 4 LEU A 471 PHE A 478 -1 O VAL A 475 N GLY A 464 SHEET 3 AA6 4 ARG A 483 TYR A 491 -1 O LEU A 484 N GLY A 477 SHEET 4 AA6 4 GLU A 496 MET A 499 -1 O ARG A 498 N CYS A 489 SHEET 1 AA7 4 GLY A 511 LEU A 515 0 SHEET 2 AA7 4 CYS A 518 ALA A 522 -1 O ALA A 522 N GLY A 511 SHEET 3 AA7 4 VAL A 534 ASP A 538 -1 O GLU A 535 N ALA A 521 SHEET 4 AA7 4 THR A 543 VAL A 547 -1 O VAL A 547 N VAL A 534 SHEET 1 AA8 4 GLY A 558 HIS A 562 0 SHEET 2 AA8 4 ARG A 565 LEU A 569 -1 O TYR A 567 N THR A 560 SHEET 3 AA8 4 SER A 580 ASP A 585 -1 O TYR A 584 N ILE A 566 SHEET 4 AA8 4 THR A 590 ARG A 596 -1 O THR A 590 N ASP A 585 SHEET 1 AA9 4 TRP B 352 ARG B 354 0 SHEET 2 AA9 4 LEU B 342 TYR B 345 -1 N ALA B 344 O LEU B 353 SHEET 3 AA9 4 LEU B 327 ALA B 331 -1 N ILE B 328 O TYR B 345 SHEET 4 AA9 4 GLY B 605 THR B 609 -1 O ALA B 607 N TYR B 329 SHEET 1 AB1 4 ALA B 366 VAL B 370 0 SHEET 2 AB1 4 LEU B 373 VAL B 377 -1 O TYR B 375 N CYS B 368 SHEET 3 AB1 4 LEU B 393 ASN B 397 -1 O TYR B 396 N LEU B 374 SHEET 4 AB1 4 GLN B 402 PRO B 405 -1 O SER B 404 N CYS B 395 SHEET 1 AB2 2 ARG B 380 SER B 383 0 SHEET 2 AB2 2 GLY B 386 ASP B 389 -1 O GLY B 386 N SER B 383 SHEET 1 AB3 4 GLY B 417 ILE B 421 0 SHEET 2 AB3 4 HIS B 424 VAL B 428 -1 O TYR B 426 N GLY B 419 SHEET 3 AB3 4 VAL B 440 TYR B 443 -1 O TYR B 443 N ILE B 425 SHEET 4 AB3 4 TRP B 450 LEU B 452 -1 O HIS B 451 N ARG B 442 SHEET 1 AB4 2 SER B 431 HIS B 432 0 SHEET 2 AB4 2 ILE B 435 HIS B 436 -1 O ILE B 435 N HIS B 432 SHEET 1 AB5 4 GLY B 464 LEU B 468 0 SHEET 2 AB5 4 LEU B 471 PHE B 478 -1 O VAL B 475 N GLY B 464 SHEET 3 AB5 4 ARG B 483 TYR B 491 -1 O GLU B 488 N ALA B 474 SHEET 4 AB5 4 GLU B 496 MET B 499 -1 O ARG B 498 N CYS B 489 SHEET 1 AB6 4 GLY B 511 LEU B 515 0 SHEET 2 AB6 4 CYS B 518 ALA B 522 -1 O ALA B 522 N GLY B 511 SHEET 3 AB6 4 VAL B 534 ASP B 538 -1 O GLU B 535 N ALA B 521 SHEET 4 AB6 4 THR B 543 VAL B 547 -1 O VAL B 547 N VAL B 534 SHEET 1 AB7 4 GLY B 558 HIS B 562 0 SHEET 2 AB7 4 ARG B 565 LEU B 569 -1 O TYR B 567 N THR B 560 SHEET 3 AB7 4 SER B 580 ASP B 585 -1 O TYR B 584 N ILE B 566 SHEET 4 AB7 4 THR B 590 ARG B 596 -1 O THR B 590 N ASP B 585 SSBOND 1 CYS A 434 CYS B 434 1555 1555 2.05 CRYST1 75.400 75.567 202.126 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013263 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013233 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004947 0.00000